|
: |
Resaerch Paper |
Title |
: |
Synthesis of New 3, 5-Diaryl-4, 5-Dihydroisoxazole-4-Carbonitriles via 1, 3-Dipolar Cycloaddition Reaction |
Country |
: |
India |
Authors |
: |
P. Jayaroopa, G. Vasanth Kumar, N. Renuka and K. Ajay Kumar |
|
: |
10.9790/5736-0142023 |
Abstract: Aromatic aldoximes 1a-i undergo oxidative dehydrogenation with CrO2 to give nitrile oxides, which are trapped in situ by 4-methoxycinnamonitrile 2 to afford of ethyl 3,5-diaryl-4,5-dihydroisoxazole-4-carbonitriles 3a-i in good yield.
Key words: Isoxazoles, isoxazolines, magtreiveTM, antimicrobial, antioxidant
[1] Rolf Huisgen, "1,3-Dipolar cycloadditions. Past and future", Angewandte Chemie Int Ed. Engl., 2, 1963, 565-632.
[2] P. Caramella, P.Grunanger in "1,3-Dipolar Cycloaddition Chemistry", ed. A. Padwa, John Wiley and Sons, New York. Vol 1, 1984, 337-345.
[3] Pinho E Melo, M.V.D. Teresa "Recent advances on the synthesis and reactivity of isoxazoles", Curr. Org. Chem., 9(10), 2005, 925-958.
[4] Patrizia Cali, Lars Naerum, Seema Mukhija, Anders Hjelmencrantz, "Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents", Bioorg. and Med. Chem. Letters, 14(24), 2004, 5997-6000.
[5] K. Ajay Kumar, M. Govindaraju, G. Vasantha Kumar, "Synthesis of isoxazoles via 1,3-dipolar cycloaddition reactions and their antimicrobial activity", Indian J. of Heterocyclic Chem,, 20, 2010, 183-84.
[6] E. Abdu Musad, R. Mohamed, B.A. Saeed, B.S. Vishwanath, K.M.L. Rai, "Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles", Bioorg. and Med. Chem. Letters, 21(12), 2011, 3536-3540.
[7] Michael Rowley, Howard B. Broughton, Ian Collins, Raymond Baker, Frances Emms, Rosemarie Marwood, Shil Patel, Smita Patel, C.Ian Ragan, Stephen B. Freedman, Paul D. Leeson, "5-(Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: A potent, selective antagonist at human cloned dopamine D4 receptors", J. Med. Chem., 39, 1996, 1943-1945.
[8] John J. Talley, David L. Brown, Jeffery S. Carter, Matthew J. Graneto, Carol M. Koboldt, Jaime L. Masferrer, William E. Perkins, Roland S. Rogers, Alexander F. Shaffer, Yan Y. Zhang, Ben S. Zweifel, Karen Seibert, "4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2", J. Med. Chem., 43, 2000, 775-777.
[9] Maria Paola Giovannoni, Claudia Vergelli, Carla Ghelardini, Nicoletta Galeotti, Alessandro Bartolini, and Vittorio Dal Piaz, "[3-Chlorophenyl)piperazinypropyl]pyridazinones and analogues as potent antinociceptive agents", J. Med. Chem., 46, 2003, 1055-1059.
[10] W.-T. Li, D.-R. Hwang, C.-P. Chen, C.-W.Shen, C.-L. Huang, T.-W. Chen, C.-H. Lin, Y.-L. Chang, Y.-Y. Chang, Y.-K. Lo, H.-Y. Tseng, C.-C. Lin, J.-S. Song, H.-C. Chen, S.-J. Chen, S.-H. Wu, C.-T. Chen, "Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agents", J. Med. Chem., 46, 2003, 1706-1715.